2nd Quarter - Report

CELGENE CORPORATION for CELGENE CORPORATION

Period 2nd Quarter 2008 Filed Jul 21, 2008 Signed by Anne Marie Finley, Vice President, Government Relations

Official filing
Firm
CELGENE CORPORATION
Client
CELGENE CORPORATION
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

pharmaceutical, biotech

LobbyistCovered position, as disclosed
ANNE MARIE FINLEY US House of Representatives, Food and Drug Admi

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Affiliated organisations

OrganisationLocation
AMERICA'S SPECIALTY MEDICINES COMP Washington, DC, US
BIONJ INC Trenton, NJ, US
BIOTECHNOLOGY INDUSTRY ORGANIZATION Washington, DC, US
CALIFORNIA HEALTHCARE INSTITUTE La Jolla, CA, US
HEALTHCARE DISTRIBUTION MANAGEMENT Arlington, VA, US
HEALTHCARE INSTITUTE OF NEW JERSEY Bridgewater, NJ, US
PHARMACEUTICAL RESEARCH AND MANUFA Washington, DC, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.